To hear about similar clinical trials, please enter your email below
Trial Title:
A Study of Cognitive Health in Survivors of Prostate Cancer
NCT ID:
NCT05540782
Condition:
Prostate Cancer
Survivorship
Conditions: Official terms:
Prostatic Neoplasms
Conditions: Keywords:
Cognitive health
Quality of Life
22-223
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Cross-Sectional
Intervention:
Intervention type:
Behavioral
Intervention name:
PROMIS-SF v2.0 -Cognitive Function 8a
Description:
Patient-Reported Outcomes (PROs)
Arm group label:
Survivors of Prostate Cancer
Summary:
The purpose of this study is to collect information that may help the researchers
understand the relationship between prostate cancer survivors' experiences of
cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid
factors), including anxiety, depression, and insomnia. The researchers will also find out
how additional things may contribute to CRCD, including social factors, the
characteristics of participants' prostate cancer, and the type of cancer treatment or
other medications they received.
Criteria for eligibility:
Study pop:
Patients from Memorial Sloan Kettering Cancer Center (MSK) and the Ralph Lauren Center
(RLC), an MSK-affiliated Harlem community clinic.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- English-speaking
- Age 18 years or older
- History of histologically documented PC of any stage
- No evidence of PC Disease
Exclusion Criteria:
- <1 month since completion of surgery, radiation, chemotherapy, or ADT
- Diagnosis of Alzheimer's disease, vascular dementia, Parkinson disease, or other
organic brain disorder
- Score >10 indicative of dementia on Blessed Orientation Memory Concentration
Gender:
Male
Gender based:
Yes
Gender description:
Prostate cancer
Minimum age:
18 Years
Maximum age:
N/A
Locations:
Facility:
Name:
Memorial Sloan Kettering Basking Ridge
Address:
City:
Basking Ridge
Zip:
07920
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Monmouth
Address:
City:
Middletown
Zip:
07748
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Bergen
Address:
City:
Montvale
Zip:
07645
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Cancer Center Suffolk - Commack
Address:
City:
Commack
Zip:
11725
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Westchester
Address:
City:
Harrison
Zip:
10604
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Cancer Center
Address:
City:
New York
Zip:
10065
Country:
United States
Facility:
Name:
Memorial Sloan Kettering Nassau
Address:
City:
Uniondale
Zip:
11553
Country:
United States
Start date:
September 8, 2022
Completion date:
September 8, 2025
Lead sponsor:
Agency:
Memorial Sloan Kettering Cancer Center
Agency class:
Other
Source:
Memorial Sloan Kettering Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05540782
https://www.mskcc.org/
